WeVote
Log In

Bill

Bill

SB 1342

Insurer Disclosures on Prescription Drug Coverage

2025 Regular Session Introduced by Ana Maria Rodriguez

Requires Florida health insurers to disclose prescription drug coverage details before enrollment to help consumers compare plans, but died in committee after facing industry opposition over implementation costs.

Died in Banking and Insurance
#subjectindex
0
WeVote Research Nonpartisan
Bill Summary · SB 1342

Legislative bill overview

SB 1342 would have required Florida health insurers to provide consumers with detailed disclosures about prescription drug coverage, including formulary information, cost-sharing amounts, and prior authorization requirements before enrollment. The bill aimed to increase transparency so patients could make informed decisions about which insurance plans best suited their medication needs.

Why is this important

Prescription drug costs and coverage restrictions significantly impact healthcare affordability and access for Florida residents. Many patients discover after enrolling that their medications aren't covered or face unexpected high costs, leading to treatment delays or non-compliance. Better upfront disclosure could help consumers avoid plans with inadequate drug coverage and reduce surprise medical expenses.

Potential points of contention

  • Industry burden: Insurers argued the disclosure requirements would be administratively costly and complex, given the thousands of drugs and frequently changing formularies in their plans
  • Regulatory scope: Questions arose about whether state-level mandates might conflict with federal insurance regulations or create compliance challenges for multi-state insurers
  • Practical effectiveness: Skeptics questioned whether detailed disclosures would meaningfully help consumers, given the technical complexity of formulary information and the difficulty of predicting future medication needs

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.